Search details
1.
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.
Ann Hematol
; 103(5): 1635-1642, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38246951
2.
Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing.
Front Oncol
; 13: 1145376, 2023.
Article
in English
| MEDLINE | ID: mdl-37064110
3.
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort.
Blood Cancer J
; 13(1): 121, 2023 08 09.
Article
in English
| MEDLINE | ID: mdl-37558684
Results
1 -
3
de 3
1
Next >
>>